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Little is known about environmental causes of childhood cancer. This is probably due to the
relative rarity of cancer in children. In the United States, cancer incidence in adults is over 20 times
greater than cancer incidence in children. The situation is compounded by the fact that two groups
of cancers, leukemias and brain and spinal tumors, account for half of all childhood cancers. The
rarity of childhood cancer renders the conduct of most cohort studies infeasible. The majority of
studies assessing potential environmental risk factors for childhood cancers have been
case-control studies, which are highly efficient for studying rare diseases. Case-control studies of
childhood cancers have been greatly facilitated by using cooperative clinical trial groups for case
identification. The national studies that have emerged utilize random-digit telephone dialing and
telephone interviewing as feasible and economic means of identifying and interviewing controls.
Other approaches such as descriptive epidemiology, ecologic studies, and studies of cancer
clusters have proven to be disappointing in elucidating environmental causes of childhood cancer.
Descriptive and ecologic studies provide no information on specific exposures of study subjects;
rather, they use population levels as surrogates for individual exposure. Studies of cancer clusters
have also proven to be disappointing. Although there are numerous difficulties in conducting
research on the causes of childhood cancer, these difficulties can be remedied by using carefully
designed and conducted studies. It should be remembered that the epidemiologic approach is
probably the most likely research venue for uncovering environmental causes of childhood
cancer. Environ Health Perspect 106(Suppl 3):881-886 (1998). http.//ehpnetl.niehs.nih.gov/
docs/1998/Suppl-3/881-886grufferman/abstract.html
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Introduction
Relatively little is known about the causes
ofcancer in childhood. In the 1950s, inter-
est was focused on in utero diagnostic radi-
ation exposure and risk of childhood
leukemia (1-3). Research interest next
focused on the genetics ofselected child-
hood cancers (4,5). The mechanism of
transplacental carcinogenesis was demon-
strated in the early 1970s (6). In reviewing
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knowledge of the etiology of childhood
cancer up until the 1980s, one is struck by
the paucity ofpublished etiologic studies
relative to those ofadult cancers. In large
part, this is due to the relative rarity of
cancer during childhood. Difficulty in the
accrual ofsufficiently large numbers of
childhood cancer cases beyond leukemia
(the type most frequent in childhood) has
probably impeded research on the etiology
ofcancers in children. More recently, pedi-
atric cooperative clinical trial groups have
been identified and tapped as an important
means for conducting etiologic research on
cancers ofchildhood (7). This has miti-
gated greatly the primary problem ofhav-
ing sufficient numbers ofsubjects to study
childhood cancers properly. However,
there remain significant problems in con-
ducting research on environmental (and
other) causes of cancer in children. This
paper will review several methodologic
issues that arise in conducting research on
environmental causes ofchildhood cancer.
TheRarity Issue
The overall annual incidence ofcancer in
U.S. children 0 to 14 years ofage at diag-
nosis is 143.9 per million for white males
and 126.9 per million for white females.
The comparable incidence rate for black
males and females is 107.2 and 107.9 per
million, respectively (8). This is in contrast
to 330.4 and 277.0 per 100,000 in white
males and females, respectively, ofall ages
(9). The comparable figures for black males
and females ofall ages are 351.3 and 227.1
per 100,000, respectively. Thus, adult inci-
dence of cancer (all ages) in the United
States is over 20 times greater than the
cancer incidence in children 0 to 14 years
ofage at diagnosis. The rarityissue becomes
even more salient when one looks at the
incidence of childhood cancers beyond
acute leukemias and brain cancers. The
U.S. annual incidence ofall leukemia is
47.8 per million in white males and 29.5
per million in white females, and for brain
and spinal tumors it is 26.4 and 23.3 in
white male and female children, respec-
tively (8). Thus, leukemias account for
51.6 and 49.5% ofall cancers in 0- to 14-
year-old white males and females, respec-
tively. Oncewe go beyond these two cancer
groups, other groups are more truly rare
diseases. For example, the incidence of
rhabdomyosarcoma (RMS) in children is
5.0 and 4.4 per million in white males and
females, and that ofosteosarcoma is 2.3 and
2.7 per million in white males and females,
respectively (8). Accrual ofsubjects for
studies of less common subsets of an
already rare group ofdiseases becomes diffi-
cult even through the use oflarge coopera-
tive treatment groups as sources ofsubjects.
As will be discussed, the rarity issue has
major impact on methodologic approaches
to the studyofchildhoodcancers.
Rarity: ABasicProblem in
ChildhoodCancerResearch
The major difficulties encountered in
attempting to do epidemiologic research
on childhood cancer result from the rela-
tive rarity ofindividual childhood cancers.
This becomes a particular problem ifone
wishes to study cancers other than acute
leukemia and brain tumors in children.
This factor has perhaps played the single
most important role in limiting our infor-
mation on the causes ofchildhood cancer.
The relative rarity ofchildhood cancers
has led to the development oflarge multi-
center cooperative clinical trial groups for
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the conduct ofcancer treatment research in
children. The two major U.S. groups are
the Children's Cancer Group (Arcadia,
CA) and the Pediatric Oncology Group
(Chicago, IL). A large proportion of all
U.S. children with cancer is treated with
protocols from the two groups. This very
practical approach to dealing with the rar-
ity issue in childhood cancer research has
proven invaluable for developing new
information on cancer treatment.
AFurtherProblem
A further problem in conducting epidemi-
ologic research on childhood cancers, and
for many adult cancers as well, is that
many environmental exposures are hard to
measure and validate and their links with
disease are often hard to detect. This has
been a particular problem in case-control
research, where information is collected on
a wide variety ofpotential environmental
exposures. The issue is further com-
pounded by the reliance on cases' and con-
trols' recall of environmental exposures.
Usually there are few, ifany, means for val-
idating exposures and even fewer biomark-
ers ofexposure available to provide better
quantification ofexposures.
SomeExcptionalEnvironmental
CausesofCancer
Sometimes the astute clinical observation of
the concordance ofa rare form ofcancer
and an uncommon environmental exposure
can lead to breakthroughs in knowledge of
cancer causation. Little confirmation of
such findings is needed when extremely
strong associations are observed. An exam-
ple ofthis is the striking causal association
between vinyl chloride exposure and angio-
sarcoma ofthe liver. The initial report of
this association was the result of astute
occupational health workers observing
three cases ofthis extremely rare cancer at
manufacturing facilities producing vinyl
chloride (10). The detection ofsuch link-
ages is enhanced when they are noted for
extremely rare cancers associated with
extremely rare exposures. For example, the
rarity ofboth disease and causal exposure
led to a breakthrough finding ofan associa-
tion between diethylstilbestrol (DES) and
dear cell vaginal adenocarcinoma in young
women (6). An astute obstetrician/gynecol-
ogist observed an unusual occurrence of
these rare vaginal cancers in young women
in his practice (6). Acase-control studywas
conducted to assess potential exposures that
might be associated with risk ofthese rare
cancers. This classic study found a striking
association between the use ofDES during
pregnancy and subsequent development of
vaginal adenocarcinoma in the young
women exposed to DES in utero (6). This
observation provided considerable impetus
to awareness ofthe mechanism oftranspla-
cental carcinogenesis. Unfortunately, obser-
vations such as these, which link extremely
rare exposures with extremely rare malig-
nancies, are themselves rare. For the vast
majority of cancers, more difficult tradi-
tional epidemiologic methods must be used
to uncover newpotential riskfactors.
Descriptiv Epidemiology
A fundamental approach frequently used to
study the epidemiology of a disease is
assessment ofthe way a disease occurs in a
population. This is often termed descriptive
epidemiology (11). One looks for unusual
patterns ofdisease occurrence in terms of
time, place, and person characteristics. For
example, is there seasonal variation in the
occurrence ofa disease? Is there a higher
incidence ofa disease in some places than
in others? Are women affected more than
men? The answers to such questions can
provide ideas (hypotheses) regarding the
underlying cause ofthe disease.
An example ofthe use of descriptive
epidemiology for developing causal hypo-
theses would be the observation of an
unusual occurrence ofcancer cases in proxi-
mity to a hazardous waste dump site. This
observation, which might well be due to
chance, can lead to further epidemiologic
study of associations between substances
in the dump site and risk of the cancers
observed. One of the difficulties with
descriptive epidemiology is that it usually
does not provide us with information
regarding the specific exposures ofthe cases.
TheTexas SharpshooterEffect
One ofthe fallacies in certain descriptive
epidemiologic observations of clusters is
termed the Texas sharpshooter effect (12).
This problem can best be illustrated by the
anecdote about the Texas sharpshooter. A
traveler passing through a small town in
Texas noted a remarkable display ofsharp-
shooting. On almost every barn he passed
there was a target with a single bullet hole
that uncannily passed through the center of
the bull's-eye. He was so intrigued by this
that he stopped at a nearby gas station to
askabout the sharpshooter. With a chuckle,
the attendant told him that the shooting
was the work of Old Joe. Old Joe would
first shoot at the side of a barn and then
paint targets centered over his bullet holes
so that each shot appeared to pass through
the center ofthe target.
Clustersandthe
SharpshooterEffect
In a random distribution ofcases ofcancer
over a geographic area, some cases will
appear to occur very close together just on
the basis of random variation. The occur-
rence ofa group ofcases of a disease close
together in time and place at the time of
their diagnosis is called a cluster. Ifsuch a
cluster is observed in relation to a sus-
pected causal environmental factor, it often
becomes a cause ofconcern.
The usual way the cluster is investi-
gated is that the time frame selected for
study is the period between the diagnosis
of the first case and the last. The geo-
graphic frame for study is often the dis-
tance between the two cases living farthest
apart. When the incidence ofthe disease in
these time and geographic frames is com-
puted, it is often alarmingly high. This
approach is similar to the Texas sharp-
shooter. In a duster investigation, the time
and space intervals become the target that
is painted around the observed cluster. It is
this post hoc definition ofthe study popu-
lation and time frame that leads to spuri-
ous and often alarming reports ofclusters
greatly in excess ofnormal expectation.
However, not all studies ofchildhood
cancer clustering are done in this post hoc
fashion. Excellent statistical methods have
been developed for assessing whether cases
occur more closely together than would be
expected by chance. These approaches usu-
ally are based on analysis ofall cases of a
disease occurring in large defined popula-
tions selected without prior observation of
clustering (13,14).
EcologicStudies
Another type ofdescriptive epidemiologic
study is the so-called ecologic study. Eco-
logic studies examine data on a population
basis without specific assessment ofindi-
vidual exposures. For example, childhood
cancer incidence could be assessed in coun-
ties in which there are chemical dump sites
and comparison made with the incidence
in counties without dump sites. The diffi-
culty with this approach is that it is not
known whether cancer cases were actually
exposed to the dump site and/or what their
levels ofexposure might have been. There
is also a likelihood that children living near
dump sites will differ in socioeconomic sta-
tus from children living in areas without
dump sites. Although ecologic studies may
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have some value in developing new hypo-
theses, they provide little in the way ofthe
ability to test causal hypotheses.
TheCohortStudy
In a cohort study, subjects are defined on
the basis of their exposure status (15).
Usually a group ofindividuals who have
been exposed to some environmental factor
are followed over time to see whether or
not they develop a disease (or diseases). A
comparable group ofunexposed individu-
als is followed similarly over time to see
whether they develop the disease(s) of
interest. This allows for comparison
between the rates ofdisease occurrence in
exposed and nonexposed persons. Often,
general population rates ofdisease occur-
rence are used for comparison rather than
control groups. Cohort studies involving
childhood cancers are infrequently done.
The childhood cancer cohort studies that
have been done usually involve well-
defined large groups ofchildren that have
had an uncommon exposure such as to
ionizing radiation.
Adlvantags andLimitaions
ofCohortStudies
A major advantage of the cohort study
approach is that it works best for evaluat-
ing the health effects of rare exposures.
Selecting and following a group ofpeople
who have had a very uncommon exposure
is more likely to yield meaningful results
than would a case-control study. It is most
unlikely that in a case-control study of
usual size, many subjects will have had a
history ofa rare exposure. Another advan-
tage ofcohort studies is that they allow for
evaluating a variety of outcomes in rela-
tionship to a particular exposure or a cate-
gory ofexposures. Thus, in a cohort study
of an occupational exposure, many out-
comes can be evaluated in relation to the
exposures being studied. This is in contrast
to the case-control study approach in
which only a single disease is studied, but
multiple potential environmental exposures
can be assessed.
A major limitation ofcohort studies is
that often it is difficult to determine the
exposure status ofpeople. It is not by acci-
dent that most cohort studies are ofoccupa-
tionally exposed people, as they can be
identified relatively easily and the quality
and quantity oftheir environmental expo-
sures can often be determined. Another
problem is posed by the inefficiency of
cohort studies for assessing rare diseases or
outcomes. To find enough cases ofthe rare
disease, even ifthe risk is high following the
exposure, extremely large cohorts ofexposed
individuals wouldhave to be followed.
Perhaps the greatest problem posed by
cohort studies is that they allow for the
assessment of associations between the
studied exposures and many different dis-
eases. By looking at a large number of
potentially associated diseases, some associ-
ations will be observed purely on the basis
ofchance. Thus, many associations reported
in the literature might be due to chance
rather than to a valid association, let alone a
causal association.
TheCase-ControlStudy
Case-control studies are the type of
epidemiologic study most frequently used
by epidemiologists to assess potential
causes of childhood cancer (16). In the
case-control study, subjects with a disease
(or health condition) are the cases. Com-
parisons are then madewith a group ofsub-
jects without the disease-the controls.
Generally, cases and controls are matched
on age, gender, and race. In studies ofrare
diseases such as childhood cancers, case-
control studies are efficient, as subjects are
selected because they have the disease of
interest. In contrast to this, in a cohort
study, very large numbers ofexposed indi-
viduals would have to be studied to detect
an elevated riskofan extremely rare cancer.
Cases and controls are usually inter-
viewed and data are collected on avarietyof
exposures they might have had prior to the
onset ofthe cases' disease. Thus, case-con-
trol studies are retrospective. Case-control
studies allow for study ofmany potential
risk factors for disease but usually permit
thestudyofonlyone disease at a time.
Advantages andLimitatons
ofCase-Control Studies
Case-control studies are most advantageous
for the study ofuncommon diseases such as
childhood cancers. Generally, case-control
studies are relatively inexpensive because
lengthy follow-up of subjects, often the
case in cohort studies, is not necessary.
However, most modern case-control
studies of childhood cancers tend to be
expensive and time-consuming because of
difficulties in collecting sufficient numbers
ofcases for study and then in identifying
sufficient numbers of matched controls.
Also, data collection usually involves per-
sonal interviews ofsubjects or surrogates,
which adds to the expense ofsuch studies.
A key advantage ofcase-control studies
is that they allow for the evaluation of
many possible causes of a disease. By
studying many potential causes, analyses
can search for interactions between envi-
ronmental causes and also allow for evalua-
tion ofpotential confounding variables.
Confounding variables are variables (expo-
sures) that are associated both with the dis-
ease andwith another exposure observed to
be associated with the disease. The other
exposure may appear to be associated with
the disease when it is really the joint associ-
ation with the confounder that is the
underlying risk factor for the disease.
Case-control studies have proven over the
years to be valuable tools for the generation
and testing ofhypotheses regarding the
causes ofcancer.
However, case-control studies are
fraught with difficulties, as are most epi-
demiologic study designs. For reasons
mentioned previously, case-control studies
are not effilcient for evaluating the role of
uncommon exposures in the etiology of a
disease. Additionally, cases and controls
have different levels ofmotivation for par-
ticipating in the study and mayhave differ-
ential reporting or recall of exposure
histories. For example, the cancer patient
might be more apt to recall remote rela-
tives that have had cancer than would a
healthy community control. Part of this
problem also results from the fact that
when a person develops a cancer, relatives
often remind that individual ofother fam-
ily members who have had the same or
similar cancers. This is an example ofselec-
tive recall. Another problem relates to the
fact that in many instances, controls for
case-control studies are biased subsets of
the population and thus not truly compa-
rable to cases. Increasingly, in case-control
studies ofchildhood cancer, random-digit
telephone dialing is used to select controls
from the same telephone area as the cases.
Thus, these controls represent comparable
individuals living in the same communi-
ties. However, if the telephone calls are
only made during the daytime, the likeli-
hood ofbeing reached for inclusion in the
study could be affected by such factors as
unemployment offamily members, family
size, and whether or not a mother stays
home to provide care for her children. As a
result, in most case-control studies of
childhood cancers, random-digit dialing is
done on evenings and weekends to avoid
such potential sources ofbias.
TheNesite Case-ControlStudy
Ahybrid ofcase-control and cohort studies,
the nested case-control study, has been
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developed (15). In this study approach, a
cohort study is used as a venue for con-
ducting a subsequent case-control study.
Cases who have developed a particular dis-
ease are identified within the cohort.
Comparable cohort members without the
disease are selected as controls for these
cases. Cases and controls are compared
with regard to prior exposure history, labo-
ratory data, or other previously collected
information. There are many efficiencies
afforded by this design. First, information
on potentially causal exposures are usually
obtained well in advance of the develop-
ment ofthe disease ofinterest. Thus, such
information is less subject to the imperfec-
tions of remote memory and biased recall
of information. Second, when laboratory
risk factors (or markers) are assessed, they
need only be studied in cases and controls
rather than in the entire cohort, thereby
reducing costs considerably, particularly
when the laboratory studies are done on
previously collected biologic specimens.
EarlyExperience Using
aCase-ControlApproach
In response to observations in 1976 that
there appeared to be an epidemic ofchild-
hood RMS in North Carolina, a case-
control study was conducted to search for
underlying causes (17). Because there was
no state cancer registry at the time, cases
were identified through North Carolina
hospitals. Thirty-three RMS cases were col-
lected over a 10-year period. Controls were
identified via state birth certificates because
it was felt that hospital controls might be a
biased subset ofNorth Carolina children.
This study attempted to uncover some
possible environmental risk factors (causes)
for RMS. Because few hypotheses existed
regarding the causes of this rare malig-
nancy, information on a wide variety of
potential causes was collected. We asked
about smoking as well as several other expo-
sures that also have adverse health effects.
The most important finding emerging from
this study was a strong association between
fathers' cigarette smoking and RMS in their
children. There was no association between
mothers' smoking and RMS in their chil-
dren. A biologically based hypothesis was
developed to explain the finding and there
seemed to be an important need to confirm
or refute it (18).
Because RMS is such a rare disease, we
searched for ways to identify larger num-
bers ofcases. We contacted the Intergroup
Rhabdomyosarcoma Study (Omaha, NE),
a cooperative clinical trials group, and they
were extremely interested in doing a
second case-control study. Although we
finally had access to large numbers ofcases,
we could not come up with an economical
and feasible means of identifying controls.
Our first attempt was to have case parents
select control families for us. This fared
poorly in peer review because it was felt to
be likely to yield a biased (nonrandom)
group ofcontrols. Our problem was finally
solved by the use of random-digit tele-
phone dialing to obtain controls. This
technique uses a random number based on
the case's telephone number. The random
number is then called to see ifa compara-
ble child resides there and ifthe family is
willing to participate.
We were then able to conduct a second,
very large case-control study of over 300
RMS cases and a matched number ofcon-
trols. It is likely that over 50% ofall U.S.
RMS cases were in our study. We found
no association between fathers' (or moth-
ers') cigarette smoking and RMS in their
children. However, when we asked about
smoking, we asked about several other
exposures that also might have adverse
health effects. These dummy variables were
used to camouflage the questions about
cigarette smoking. Much to our surprise,
we found that parents' use of recreational
drugs (marijuana and cocaine) was strongly
associated with RMS risk in their children.
Thus, one of our dummy variables was
associated with risk ofRMS (19).
WhatCan BeLeaned
fromThis Experience?
The most important lesson emerging from
this experience was that cooperative clinical
trial groups are excellent venues for the con-
duct ofcase-control studies ofchildhood
cancer, particularly for the extremely rare
cancers ofchildhood (7). It also demon-
strated that techniques for control selection
such as random-digit dialing render the
conduct of national case-control studies
feasible. The reason for the conduct of
studies that are national in scope and use
subjects from cooperative clinical trial
groups is that it allows for the accession of
sufficiently large numbers ofsubjects with
extremely rare cancers to allow for proper
statistical analyses. It also yields a relatively
representative group ofcases.
This experience also illustrates that
case-control studies can assess many
potential causes ofa disease and some of
the suspected risk factors will prove to be
associated with the disease merely on the
basis of chance-the Achilles heel of
case-control research. Although there has
been much criticism ofcase-control studies
regarding the assessment-ofso many poten-
tial risk factors that they often generate false
leads, the problem lies not in the method-
ologic approach but in how the analyses are
done and how the data are interpreted and
promulgated to the public. Simply stated,
results from case-control studies must be
confirmed by other case-control studies in
other populations before they can be
accepted. Case-control studies are excellent
tools for developing new etiologic hypothe-
ses. They are also excellent tools for generat-
ing chance associations--that-may then result
in misleading hypotheses. Investigators con-
ducting case-control studies must exert pru-
dence in their analyses and interpretation of
their data. Good scientific investigation
requires a healthy degree ofskepticism for
one's own as well as others' new scientific
findings. Thus, investigators should not
rush out and hold press conferences when
they find a new and sensational association
that may or may not be due to chance and
has yet to be confirmed. The downside of
this is that the process ofdoing epidemi-
ologic research on rare cancers via case-
control studies is a slow one requiring
testing and retesting ofhypotheses. Given
the rarity of most childhood cancers, the
accrual ofsufficient numbers ofsubjects for
study often takes years. Thus, the entire
process from the observation ofa new asso-
ciation to its confirmation may be a matter
of a decade or more. Unfortunately, for
many rare cancers, this process cannot be
accelerated; great patience is required.
Recommendations forFuture
StudiesofChildhoodCancer
My first recommendation is that break-
throughs in our understanding of the
environmental causes ofchildhood cancer
are just as likely to result from studies of
rare cancers as from studies of more com-
mon cancers. Thus, studies ofdiseases that
may be of little public health impact can
yield important knowledge regarding the
causation ofchildhood cancer.
Over the years there has been great
interest in studying unusual dusters ofdis-
ease, particularly clusters ofcancer. Almost
all ofthe clustering studies done have failed
to yield new knowledge about the environ-
mental causes ofchildhood cancer. The post
hoc nature ofmost cluster investigations has
yielded results suggesting strikingexcesses of
cancers in certain locales. However, these
reports generally tend to be meaningless and
serve to alarm the public unnecessarily.
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There has also been increasing interest in
conducting ecologic studies ofenvironmen-
tal factors in childhood cancer. Such studies
might look at the relationship between resi-
dence near a dump site and the occurrence
ofchildhood cancer in its immediate vicin-
ity. These studies suffer from a lack ofspe-
cific exposure data for the subjects involved.
They are also likely to be confounded by
socioeconomic and other factors. Thus, it is
highly unlikely that useful information can
be obtained on environmental causes from
such studies.
Cohort studies ofenvironmental causes
ofchildhood cancerwould be extremely dif-
ficult and unlikely to yield important new
information other than in special situations.
Usually, it is very difficult to identify a large
enough cohort ofchildren with a common
set ofexposures for study. It should be
remembered that childhood cancers are
extremely rare and thus huge cohorts would
have to be assembled to generate sufficient
numbers ofchildren with the cancer at issue
to derive meaningful results. Cohort studies
ofparents' occupational exposures and risk
ofcancer in their children should only be
done when specific exposure data are avail-
able. Numerous such studies have been
published (20). However, these studies have
tended to be lacking in information on the
type, dose, and timing ofthe parents' occu-
pational exposures. Thus, iffurther studies
are to be done and not add to the confusion
in the literature, they should only be done
in situations in which precise exposure
information can be obtained.
Traditional case-control studies that
rely predominantly on interview data are
unlikely to yield new information on
environmental causes ofchildhood cancer.
Most childhood cancers have already been
studied in this manner. Well-designed
large case-control studies that involve
biologic information or that validate
exposure information are likely to yield
important new information. Such studies
should be multidisciplinary and large in
size to allow for proper evaluation ofcausal
interactions and potential confounding
variables. Such studies would be relatively
expensive because oftheir increased com-
plexity; however, this expense would be
well justified.
Because it is often the case that the
specific level ofexposure of a child to a
suspected environmental risk factor is
unknown, it would be highly desirable to
have some biologic measure ofpast expo-
sure. Unfortunately, few biomarkers of
exposure levels are currently available.
Biomarkers ofcancer risk following envi-
ronmental exposures would be high on
many epidemiologists' wish lists. The avail-
ability of inexpensive, reliable, and valid
laboratory measures ofenvironmental expo-
sures, cancer risk, or individual susceptibil-
ity would greatly strengthen epidemiologic
studies ofenvironmental risk factors for
childhood cancer (21). It would particu-
larly facilitate ecologic and case-control
studies. Development ofsuch biomarkers
should be apriorityarea forfuture research.
It is likely that genetic factors (i.e.,
hereditary susceptibility) play an important
role in the etiology of many cancers of
childhood. Children with a genetic predis-
position for cancer may be particularly
sensitive to environmental carcinogenic
exposures. The Knudson two-mutation
hypothesis offamilial cancer occurrence is
consistent with this notion (4). Thus, it
should be fruitful in future epidemiologic
research on childhood cancer to consider
genetic-environmental interactions. The
difficulty in conducting such research
hinges on the rarity of most genetically
related cancers ofchildhood. Again, the
availability of a useful and economical
laboratory measure ofgenetic susceptibility
to childhood cancer would be a boon to
epidemiologic research.
Another area for future research is the
role ofenvironmental factors in the causa-
tion of second malignancy in cancer
patients. As treatment ofchildhood cancer
becomes more successful, many patients
will survive into adulthood. Some ofthese
patients will develop second cancers, most
ofwhich are believed to be due to cancer
therapy effects or to genetic predisposi-
tion. The question arises as to whether a
cancer survivor's risk of second cancer
might be increased further by environ-
mental factors such as occupational expo-
sures. This is a potentially fruitful area for
new research.
In summary, there are numerous diffi-
culties in conducting research aimed at elu-
cidating the causes of childhood cancer.
However, these difficulties are not insur-
mountable and can be remedied by the
conduct of carefully designed and con-
ducted studies. It must be remembered
that the epidemiologic approach is proba-
bly the most likely research venue for
uncovering the causes ofchildhood cancer.
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